Ryan J W, Valido F A, Sequeira M J, Chung A Y, Berryer P, Chen X L, Catravas J D
Department of Medicine, University of Miami School of Medicine, Florida.
J Pharmacol Exp Ther. 1994 Jul;270(1):260-8.
We developed a method of measuring the mole quantity of pulmonary angiotensin-converting enzyme (ACE) bound by a partially saturating dose of an ACE inhibitor injected i.v. For each test animal (11 guinea pigs), tracer (nonsaturating) doses of the ACE substrate [14C]benzoyl-Ala-Gly-Pro (14C-BAGP) and the ACE inhibitor 3H-RAC-X-65 were coinjected at timed intervals for a total of four studies per animal. The injectate used for the second study contained, in addition, a partially saturating dose of unlabeled RAC-X-65. With indicator-dilution techniques supplemented with measurements of fractional hydrolysis of 14CBAGP and uptake of 3H-RAC-X-65 during a single transit through the pulmonary vascular bed, the following parameters were computed: plasma flow (Qp), (kcat/Km)[E] vector c, k1[E] vector c and Eb, where [E] is the concentration of active ACE, Eb is the mole quantity of ACE bound by inhibitor, kcat/Km is the second-order rate constant for substrate hydrolysis, k1 is the inhibitor-ACE association rate constant and vector c is capillary mean transit time. As shown elsewhere (Catravas et al., 1990; Catravas and White, 1984), the product of Qp (in liters per second) multiplied by (kcat/Km)[E] vector c is (kcat/Km)E, and the product of Qp multiplied by k1[E] vector c is k1E, where E is the mole quantity of ACE. Values of (kcat/Km)Eb and k1Eb were computed and divided by Eb to obtain kcat/Km and k1. The fractional degree of inhibition conferred by a partially saturating dose of an ACE inhibitor can be understood to be the ratio Eb/ET, where ET is total ACE. With Eb in moles and the ratio Eb/ET, we computed the mole quantity of ET. By measuring the rate of recovery of ACE activity following partial inhibition of ACE, an apparent dissociation rate constant, k(dissoc), was computed. With k(dissoc) and K1, an apparent Ki was computed. The following computations were obtaine: ET of 0.90 +/- 0.20 (S.E.M.) nmol; kcat/Km, 5.16 +/- 0.89E + 06 M-1.sec-1; k1, 1.26 +/- 0.21E + 06 M-1.sec-1; k(dissoc), 6.47 +/- 0.63E - 04 sec-1 and Ki, 5.13E - 10 M. Although we focused on the characterization of ACE, the methods developed are general and may be applicable to studies of other vascular surface proteins, including other enzymes and hormone receptors.
我们开发了一种测量静脉注射部分饱和剂量的血管紧张素转换酶(ACE)抑制剂所结合的肺ACE摩尔量的方法。对于每只实验动物(11只豚鼠),在不同时间间隔共同注射示踪剂(非饱和)剂量的ACE底物[¹⁴C]苯甲酰 - 丙氨酰 - 甘氨酰 - 脯氨酸(¹⁴C - BAGP)和ACE抑制剂³H - RAC - X - 65,每只动物共进行四项研究。用于第二项研究的注射剂还含有部分饱和剂量的未标记RAC - X - 65。通过指示剂稀释技术,并辅以单次通过肺血管床期间¹⁴C - BAGP的水解分数和³H - RAC - X - 65摄取量的测量,计算了以下参数:血浆流量(Qp)、(kcat/Km)[E]向量c、k1[E]向量c和Eb,其中[E]是活性ACE的浓度,Eb是被抑制剂结合的ACE摩尔量,kcat/Km是底物水解的二级速率常数,k1是抑制剂 - ACE结合速率常数,向量c是毛细血管平均通过时间。如其他文献所示(卡特拉瓦斯等人,1990年;卡特拉瓦斯和怀特,1984年),Qp(以升/秒为单位)乘以(kcat/Km)[E]向量c的乘积是(kcat/Km)E,Qp乘以k1[E]向量c的乘积是k1E,其中E是ACE的摩尔量。计算(kcat/Km)Eb和k1Eb的值,并除以Eb以获得kcat/Km和k1。部分饱和剂量的ACE抑制剂所赋予的抑制分数程度可理解为Eb/ET的比值,其中ET是总ACE。已知Eb的摩尔数和Eb/ET的比值,我们计算了ET的摩尔量。通过测量ACE部分抑制后ACE活性的恢复速率,计算了表观解离速率常数k(dissoc)。结合k(dissoc)和K1,计算了表观Ki。得到以下计算结果:ET为0.90±0.20(标准误)nmol;kcat/Km为5.16±0.89×10⁶ M⁻¹·秒⁻¹;k1为1.26±0.21×10⁶ M⁻¹·秒⁻¹;k(dissoc)为6.47±0.63×10⁻⁴ 秒⁻¹,Ki为5.13×10⁻¹⁰ M。尽管我们重点关注ACE的特性,但所开发的方法具有通用性,可能适用于其他血管表面蛋白的研究,包括其他酶和激素受体。